Angel investor · Seattle, United States
Recorded investments.
A clearer sense of fit.
Find where your company fits, how rounds are assembled, and what happened after the first investment.
of dated first investments
were at Angel, Pre-Seed or Seed
One dot = one company at first recorded investment.
Written insights from the recorded portfolio, with the evidence linked below.
Bill Gates has dated investments in 45 companies. 10 first entries were at Angel, Pre-Seed or Seed (22.2%). An early-stage founder can use the sector and stage filters to find comparable companies before approaching the investor.
Explore the evidence ↗1 first company relationships appear in the latest 24 months, compared with 2 in the preceding window. The latest recorded investment is 2024-05-28. This describes observed activity through 2026-05-22; it does not establish current availability.
Explore the evidence ↗24 of 44 companies with a full 24-month observation window raised another equity round. This investor backed 5 of those companies again within that window. The difference is a reason to research the wider syndicate, rather than assume the same investor will fund the next round.
Explore the evidence ↗Life Sciences is the largest displayed sector by company count, appearing in 9 portfolio companies; sector tags overlap. 15 first entries carry a recorded lead flag and the median first-round syndicate includes 5 other named backers. Shared rounds are evidence of co-investment, not evidence of an introduction route.
Explore the evidence ↗Start with observed behavior.
Every rate has a defined denominator.
25th–75th percentile across 39 disclosed first rounds. Total round size; the investor’s own cheque is undisclosed.
Size your round ↗22 May 2024–22 May 2026, versus 2 in the preceding 24 months.
See the rhythm ↗24 of 44 companies with a full observation window. The next round can include any investor.
Follow the path ↗5 of the same 44 companies. Build a financing plan around the wider investor market.
Explore co-investors ↗Choose your sector and stage to find
companies he first backed in that space.
A match means a recorded investment in this category. It does not establish current interest or availability.
All sectors · All entry stages. Round amounts are total financing, in USD.
Developer of drugs for treating neurological disorders
$11M total first roundDeveloper of programmable optics technology for 3D sensing and communications
Undisclosed total first roundDeveloper of a web-based solar power plant optimization platform
$44M total first round| Sector | Angel | Seed | Series A | All stages |
|---|---|---|---|---|
| Life Sciences | 9 | |||
| Renewable Energy Tech | 5 | |||
| FinTech | 4 | |||
| Energy Storage Tech | 4 | |||
| Food Tech | 4 | |||
| Novel Foods | 4 | |||
| Circular Economy | 3 |
Use stage-specific financing ranges
to frame the size of your syndicate.
Logarithmic scale. A dot marks the median; the band spans the 25th–75th percentiles. These are entire rounds, not individual cheques.
A subsequent round and repeat backing
answer different fundraising questions.
Includes first investments on or before 22 May 2024. 1 newer companies and 0 undated histories are excluded. Follow-up stops at the dataset’s latest round on 22 May 2026. These observations do not measure returns or predict a company’s outcome.
| First stage | Eligible companies | Next round ≤24 mo | Same investor again ≤24 mo |
|---|---|---|---|
| Angel | 3 | 1 / 3 | 0 / 3 |
| Seed | 7 | 3 / 7 | 0 / 7 |
| Series A | 11 | 8 / 11 | 0 / 11 |
| Series B | 10 | 6 / 10 | 3 / 10 |
| Series C | 7 | 1 / 7 | 0 / 7 |
| Series D | 5 | 4 / 5 | 2 / 5 |
| Series E+ | 1 | 1 / 1 | 0 / 1 |
Separate first investments from later
rounds in companies already backed.
*2026 is partial, through 22 May. Bar height counts first investments + repeat rounds; earlier years are complete calendar periods in this dataset.
Frequent shared rounds suggest a place
to investigate sector and stage alignment.
17 shared rounds · 6 companies
Latest shared round Feb 202211 shared rounds · 6 companies
Latest shared round May 20227 shared rounds · 7 companies
Latest shared round Aug 20227 shared rounds · 2 companies
Latest shared round Aug 20207 shared rounds · 4 companies
Latest shared round Apr 2022Shared rounds establish recorded co-investment. They do not establish a personal connection, introduction route, or current willingness to invest.
First investment comes first.
Amounts refer to that entry round.
| Company | First backed | Entry stage | Total entry round | Same investor again? |
|---|---|---|---|---|
Lucy Therapeutics ↗Cambridge | May 2024 | Series B | $11M | No later round recorded |
Lumotive ↗Bellevue | Aug 2022 | Seed | Undisclosed | No later round recorded |
Terabase ↗Berkeley | Aug 2022 | Series B | $44M | No later round recorded |
Inflection ↗Palo Alto | Apr 2022 | Series D | $225M | Yes · Jun 2023 |
Neutral ↗Portland | Apr 2022 | Series A | Undisclosed | No later round recorded |
Luminous ↗Mountain View | Mar 2022 | Series A | $105M | No later round recorded |
HUBUC ↗Barcelona | Feb 2022 | Seed | $10M | No later round recorded |
Modern Hydrogen ↗Bothell | Dec 2021 | Series B | $30M | No later round recorded |
CFS ↗Cambridge | Dec 2021 | Series B | $1.8B | No later round recorded |
Form Energy ↗Somerville | Jul 2021 | Series D | $155M | No later round recorded |
Nature's Fynd ↗Chicago | Jul 2021 | Series C | $350M | No later round recorded |
Redwood Materials ↗Carson City | May 2021 | Series C | $777M | No later round recorded |
H2PRO ↗Caesarea | Mar 2021 | Series A | $25M | No later round recorded |
Vicarious Surgical ↗Boston | Aug 2020 | Series A | $13M | No later round recorded |
Cerevance ↗Cambridge | Apr 2020 | Series B | $45M | No later round recorded |
minu ↗Miguel Hidalgo | Sep 2019 | Seed | $6.5M | No later round recorded |
New Street Tech ↗Bengaluru | Mar 2019 | Seed | $2.0M | No later round recorded |
Kallyope ↗New York City | Dec 2018 | Series B | $21M | Yes · Mar 2020 |
DMC ↗Boulder | Oct 2018 | Seed | Undisclosed | No later round recorded |
Beyond Meat ↗El Segundo | Sep 2018 | Series E+ | $15M | No later round recorded |
Carillon Technologies ↗Arlington | Sep 2018 | Angel | Undisclosed | No later round recorded |
| Aug 2018 | Series A | $5.8M | No later round recorded | |
Stream ↗Arlington | Aug 2018 | Series A | $5.8M | No later round recorded |
Apeel ↗Goleta | Jun 2018 | Angel | Undisclosed | No later round recorded |
Nimbus Therapeutics ↗Cambridge | Jun 2018 | Series C | $65M | Yes · Sep 2022 |
Fictiv ↗San Francisco | May 2018 | Series B | $15M | Yes · Mar 2019 |
| Apr 2018 | Seed | Undisclosed | No later round recorded | |
Ginkgo Bioworks ↗Boston | Dec 2017 | Series D | $275M | No later round recorded |
Mainspring Energy ↗Menlo Park | Aug 2017 | Series C | $83M | Yes · Dec 2020 |
Upside Foods ↗Berkeley | Aug 2017 | Series A | $22M | Yes · Apr 2020 |
Pivotal Commware ↗Kirkland | Jun 2017 | Series A | $17M | Yes · Feb 2021 |
Evolv Technology ↗Waltham | Mar 2017 | Series B | $18M | Yes · Jan 2020 |
Renmatix ↗King Of Prussia | Sep 2016 | Series D | $14M | No later round recorded |
GRAIL ↗Menlo Park | Jan 2016 | Series A | $100M | No later round recorded |
Impossible Foods ↗Redwood City | Aug 2015 | Series D | $108M | Yes · Jul 2017 |
Echodyne ↗Kirkland | Dec 2014 | Series A | $15M | Yes · May 2017 |
Change ↗India | Dec 2014 | Series C | $25M | Yes · May 2017 |
Ambri ↗Marlborough | May 2014 | Series C | $35M | Yes · Aug 2021 |
Evolv ↗Waltham | Oct 2013 | Series A | $12M | Yes · Mar 2017 |
Varentec ↗Santa Clara | Sep 2013 | Series B | $8.1M | Yes · Aug 2016 |
ResearchGate ↗Berlin | May 2013 | Series C | $35M | Yes · Feb 2017 |
Schrodinger ↗New York City | Dec 2012 | Angel | $20M | No later round recorded |
Kymeta ↗Seattle | Aug 2012 | Series B | $12M | Yes · Jul 2013 |
NEOS GeoSolutions ↗Houston | Jan 2011 | Series B | $60M | No later round recorded |
Carbon Engineering ↗Squamish | Jun 2009 | Seed | $3.5M | Yes · Mar 2019 |
No companies match these filters. Try a broader sector or stage.
Kept in the 45-company portfolio; excluded from entry-timing calculations.
Search Seattle, United States investor companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.
Explore companies in Radar ↗We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.
Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.
Explore Fliar Prism ↗Start with the company or question you want to understand.